Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00088556. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1-2a Dose-Ranging Study of the Triplet Combination of Carboplatin, Paclitaxel and TLK286 as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this trial is to study the efficacy and safety of the triplet combination of TLK286, carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.
Study identification
- NCT ID
- NCT00088556
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2004
- Primary completion
- Apr 30, 2009
- Completion
- Apr 30, 2009
- Last update posted
- May 30, 2012
2004 – 2009
United States locations
- U.S. sites
- 52
- U.S. states
- 12
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bay Area Cancer Research Group | Concord | California | 94520 | — |
| East Bay Medical Oncology/Hematology Associates | Concord | California | 94520 | — |
| Southwest Cancer Care | Escondido | California | 92025 | — |
| Kaiser Permanente Medical Center | Hayward | California | 94545 | — |
| Southwest Cancer Care | Murrieta | California | 92562 | — |
| Kaiser Permanente Medical Center | Oakland | California | 94611 | — |
| Southwest Cancer Care | Poway | California | 92064 | — |
| Kaiser Permanente Medical Center | Sacramento | California | 95825 | — |
| Kaiser Permanente Medical Center | San Francisco | California | 94115 | — |
| Kaiser Permanente Medical Center | San Jose | California | 95119 | — |
| Kaiser Permanente Medical Center | Santa Clara | California | 95051 | — |
| Kaiser Permanente Medical Center | So. San Francisco | California | 94080 | — |
| Kaiser Permanente Medical Center | Vallejo | California | 94589 | — |
| Diablo Valley Oncology & Hematology Medical Group | Walnut Creek | California | 94520 | — |
| Kaiser Permanente Medical Center | Walnut Creek | California | 94596 | — |
| Citrus Hematology and Oncology | Crystal River | Florida | 34429 | — |
| Citrus Hematology and Oncology Center | Inverness | Florida | 34452 | — |
| Florida Wellcare Alliance, LC | Inverness | Florida | 34452 | — |
| Kansas City Cancer Center | Kansas City | Kansas | 66112 | — |
| Kansas City Cancer Center - Central Research Dept. Data Office & Drug Discovery Location | Lenexa | Kansas | 66214 | — |
| Kansas City Cancer Center | Overland Park | Kansas | 66210 | — |
| Department of Veterns Affairs - Overton Brooks VA Medical Center | Shreveport | Louisiana | 71101 | — |
| LSU Health Sciences Center | Shreveport | Louisiana | 71103 | — |
| University of Maryland, Baltimore University of Maryland Medical System-Greenebaum Cancer Center | Baltimore | Maryland | 21201 | — |
| Center for Cancer and Blood Disorders, P. C. | Bethesda | Maryland | 20817 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02115 | — |
| Brigham & Women's Hospital | Boston | Massachusetts | 02115 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Kansas City Cancer Center | Kansas City | Missouri | 64111 | — |
| Kansas City Cancer Center | Kansas City | Missouri | 64131 | — |
| Kansas City Cancer Center | Kansas City | Missouri | 64154 | — |
| Kansas City Cancer Center | Lee's Summit | Missouri | 64064 | — |
| St. John's Mercy Medical Center | St Louis | Missouri | 63141 | — |
| St. John's Mercy Hospital | Washington | Missouri | 63090 | — |
| Clinical Research Service | Scottsbluff | Nebraska | 69361 | — |
| Horizons West Medical Group | Scottsbluff | Nebraska | 69361 | — |
| Dakota Cancer Institute | Fargo | North Dakota | 58103 | — |
| Odyssey Research | Fargo | North Dakota | 58104 | — |
| Tennessee Oncology, PLLC | Clarksville | Tennessee | 37043 | — |
| Tennessee Oncology, PLLC | Franklin | Tennessee | 37067 | — |
| Tennessee Oncology, PLLC | Hermitage | Tennessee | 37076 | — |
| Tennessee Oncology, PLLC | Lebanon | Tennessee | 37087 | — |
| Tennessee Oncology, PLLC | Murfreesboro | Tennessee | 37130 | — |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | — |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37205 | — |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37207 | — |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37211 | — |
| Tennessee Oncology, PLLC | Smyrna | Tennessee | 37167 | — |
| Texas Cancer Associates | Dallas | Texas | 75231 | — |
| Texas Cancer Associates | Plano | Texas | 75093 | — |
| Danville Hematology & Oncology, Inc. | Danville | Virginia | 24541 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00088556, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2012 · Synced Sep 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00088556 live on ClinicalTrials.gov.